Annual Current Liabilities
$580.98 M
-$22.12 M-3.67%
December 31, 2024
Summary
- As of March 10, 2025, PTCT annual total current liabilities is $580.98 million, with the most recent change of -$22.12 million (-3.67%) on December 31, 2024.
- During the last 3 years, PTCT annual current liabilities has risen by +$71.63 million (+14.06%).
- PTCT annual current liabilities is now -3.67% below its all-time high of $603.10 million, reached on December 31, 2023.
Performance
PTCT Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Current Liabilities
$580.98 M
-$29.73 M-4.87%
December 31, 2024
Summary
- As of March 10, 2025, PTCT quarterly total current liabilities is $580.98 million, with the most recent change of -$29.73 million (-4.87%) on December 31, 2024.
- Over the past year, PTCT quarterly current liabilities has stayed the same.
- PTCT quarterly current liabilities is now -4.87% below its all-time high of $610.71 million, reached on September 30, 2024.
Performance
PTCT Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Current Liabilities Formula
Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities
PTCT Current Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -3.7% | 0.0% |
| 3 y3 years | +14.1% | +18.1% |
| 5 y5 years | +146.3% | +18.1% |
PTCT Current Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -3.7% | +43.0% | -4.9% | +43.0% |
| 5 y | 5-year | -3.7% | +146.3% | -4.9% | +187.8% |
| alltime | all time | -3.7% | +4323.5% | -4.9% | +6188.4% |
PTC Therapeutics Current Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $580.98 M(-3.7%) | $580.98 M(-4.9%) |
| Sep 2024 | - | $610.71 M(+0.1%) |
| Jun 2024 | - | $609.80 M(+6.1%) |
| Mar 2024 | - | $574.55 M(-4.7%) |
| Dec 2023 | $603.10 M(+48.5%) | $603.10 M(+22.6%) |
| Sep 2023 | - | $492.12 M(+3.3%) |
| Jun 2023 | - | $476.34 M(+7.9%) |
| Mar 2023 | - | $441.63 M(+8.7%) |
| Dec 2022 | $406.24 M(-20.2%) | $406.24 M(-3.3%) |
| Sep 2022 | - | $420.08 M(-26.0%) |
| Jun 2022 | - | $567.37 M(+19.0%) |
| Mar 2022 | - | $476.78 M(-6.4%) |
| Dec 2021 | $509.35 M(+83.7%) | $509.35 M(+9.5%) |
| Sep 2021 | - | $465.26 M(+59.9%) |
| Jun 2021 | - | $290.96 M(+15.9%) |
| Mar 2021 | - | $250.95 M(-9.5%) |
| Dec 2020 | $277.33 M(+17.6%) | $277.33 M(+9.3%) |
| Sep 2020 | - | $253.82 M(+25.8%) |
| Jun 2020 | - | $201.84 M(-7.3%) |
| Mar 2020 | - | $217.67 M(-7.7%) |
| Dec 2019 | $235.86 M(+41.4%) | $235.86 M(+28.5%) |
| Sep 2019 | - | $183.50 M(+5.5%) |
| Jun 2019 | - | $173.96 M(+21.6%) |
| Mar 2019 | - | $143.05 M(-14.2%) |
| Dec 2018 | $166.80 M | $166.80 M(+45.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2018 | - | $114.92 M(+32.9%) |
| Jun 2018 | - | $86.47 M(+18.9%) |
| Mar 2018 | - | $72.72 M(-11.4%) |
| Dec 2017 | $82.05 M(+65.3%) | $82.05 M(+14.1%) |
| Sep 2017 | - | $71.90 M(+5.8%) |
| Jun 2017 | - | $67.98 M(+49.7%) |
| Mar 2017 | - | $45.42 M(-8.5%) |
| Dec 2016 | $49.62 M(+9.3%) | $49.62 M(+1.4%) |
| Sep 2016 | - | $48.93 M(+14.0%) |
| Jun 2016 | - | $42.91 M(-2.2%) |
| Mar 2016 | - | $43.89 M(-3.3%) |
| Dec 2015 | $45.39 M(+39.8%) | $45.39 M(+43.2%) |
| Sep 2015 | - | $31.70 M(+37.3%) |
| Jun 2015 | - | $23.08 M(-3.4%) |
| Mar 2015 | - | $23.91 M(-26.4%) |
| Dec 2014 | $32.48 M(+147.3%) | $32.48 M(+88.1%) |
| Sep 2014 | - | $17.26 M(+49.0%) |
| Jun 2014 | - | $11.58 M(+25.4%) |
| Mar 2014 | - | $9.24 M(-29.7%) |
| Dec 2013 | $13.13 M(-53.4%) | $13.13 M(-5.7%) |
| Sep 2013 | - | $13.92 M(-29.7%) |
| Jun 2013 | - | $19.79 M(-27.6%) |
| Mar 2013 | - | $27.33 M(-3.0%) |
| Dec 2012 | $28.16 M(-34.7%) | $28.16 M |
| Dec 2011 | $43.15 M | - |
FAQ
- What is PTC Therapeutics annual total current liabilities?
- What is the all time high annual current liabilities for PTC Therapeutics?
- What is PTC Therapeutics annual current liabilities year-on-year change?
- What is PTC Therapeutics quarterly total current liabilities?
- What is the all time high quarterly current liabilities for PTC Therapeutics?
- What is PTC Therapeutics quarterly current liabilities year-on-year change?
What is PTC Therapeutics annual total current liabilities?
The current annual current liabilities of PTCT is $580.98 M
What is the all time high annual current liabilities for PTC Therapeutics?
PTC Therapeutics all-time high annual total current liabilities is $603.10 M
What is PTC Therapeutics annual current liabilities year-on-year change?
Over the past year, PTCT annual total current liabilities has changed by -$22.12 M (-3.67%)
What is PTC Therapeutics quarterly total current liabilities?
The current quarterly current liabilities of PTCT is $580.98 M
What is the all time high quarterly current liabilities for PTC Therapeutics?
PTC Therapeutics all-time high quarterly total current liabilities is $610.71 M
What is PTC Therapeutics quarterly current liabilities year-on-year change?
Over the past year, PTCT quarterly total current liabilities has changed by $0.00 (0.00%)